Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives

• Published in: Molecular diagnosis & therapy Vol. 29; no. 1; pp. 55 - 66
• Main Authors: Guglielmo, Priscilla, Crivellaro, Cinzia, Castello, Angelo, Della Corte, Carminia Maria, Pagano, Maria, Marchesi, Silvia, Occhipinti, Mario, Zucali, Paolo Andrea, Evangelista, Laura
• Format: Journal Article
• Language: English
• Published: New Zealand Springer Nature B.V 01.01.2025
• Subjects: Abdomen; Asbestos; Biopsy; Computed tomography; Content analysis; Diagnostic systems; Diagnostic tests; Fibroblast activation protein; Fibroblasts; Fluorine; Fluorine isotopes; Fluorodeoxyglucose F18 - chemistry; Gallium; Humans; Lymph nodes; Lymphatic system; Magnetic resonance imaging; Medical imaging; Medical prognosis; Mesothelioma; Mesothelioma - diagnosis; Mesothelioma - diagnostic imaging; Mesothelioma - pathology; Mesothelioma, Malignant; Metastasis; Methionine; Patients; Pharmaceuticals; Positron emission; Positron emission tomography; Positron Emission Tomography Computed Tomography - methods; Positron-Emission Tomography - methods; Radioisotopes; Radiopharmaceuticals - chemistry; Sensitivity analysis; Tomography

Mesothelioma is a malignant tumor associated primarily with asbestos exposure, characterized by an aggressive nature and poor prognosis. Accurate diagnosis, staging, and monitoring of therapeutic response are crucial for effective patient management. Along with a computed tomography (CT) scan, fluor...